Emergent BioSolutions
EBS
#8541
Rank
A$0.39 B
Marketcap
A$7.73
Share price
-6.36%
Change (1 day)
-49.24%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -A$0.29 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are A$0.62 Billion. In 2025 the company made an earning of A$0.21 Billion, an increase over its 2024 earnings that were of -A$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.29 Billion-232.61%
2025 A$0.21 B-297.64%
2024 -A$0.11 Billion-88.82%
2023 -A$0.97 Billion242.73%
2022 -A$0.29 Billion-153.8%
2021 A$0.52 B-20.43%
2020 A$0.65 B278.02%
2019 A$0.17 B27.11%
2018 A$0.13 B-27.12%
2017 A$0.18 B17.21%
2016 A$0.16 B0.45%
2015 A$0.15 B73.51%
2014 A$92.06 M41.36%
2013 A$65.13 M35.2%
2012 A$48.17 M0.4%
2011 A$47.98 M-56.46%
2010 A$0.11 B76.73%
2009 A$62.35 M32.94%
2008 A$46.9 M-5.62%
2007 A$49.7 M
2005 A$71.95 M269.89%
2004 A$19.45 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.46 B-3,680.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.09 B-3,554.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$10.74 B-3,776.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-A$17.58 Million-93.99%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-A$16.73 Million-94.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.49 Billion 67.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.83 B-728.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel